Incidence and natural history of Raynaud phenomenon: a long-term follow-up (14 years) of a random sample from the general population

Journal of Vascular Surgery

Volumn 44, Issue 5, 2006, Pages 1023-1028

  Carpentier, Patrick H ^a,b   Satger, Bernadette ^a,b   Poensin, Dominique ^a   Maricq, Hildegard R ^c  

^a Centre de Recherche Universitaire   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RANDOMIZATION; RAYNAUD PHENOMENON; SCLERODERMA; SCLEROSIS; TELEPHONE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROGNOSIS; RAYNAUD DISEASE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 33846234748     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.07.037     Document Type: Article

References (30)

1. Maricq H.R., Harper F.E., Khan M.M., Tan E.M., and LeRoy E.C. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1 (1983) 195-205
2. Gerbracht D.D., Steen V.D., Ziegler G.L., Medsger Jr. T.A., and Rodnan G.P. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum 28 (1985) 87-92
3. Priollet P., Vayssairat M., and Housset E. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases. Am J Med 83 (1987) 494-498
4. Sheiner N.M., and Small P. Isolated Raynaud's phenomenon-a benign disorder. Ann Allergy 58 (1987) 114-117
5. Kallenberg C.G., Wouda A.A., Hoet M.H., and Van Venrooij W.J. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47 (1988) 634-641
6. Fitzgerald O., Hess E.V., O'Connor G.T., and Spencer-Green G. Prospective study of the evolution of Raynaud's phenomenon. Am J Med 84 (1988) 718-726
7. Wollersheim H., Thien T., Hoet M.H., and Van Venrooy W.J. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon. Eur J Clin Invest 19 (1989) 535-541
8. Gentric A., Blaschek M.A., Le Noach J.F., Johanet C., Jouquan J., Lamour A., et al. Serological arguments for classifying Raynaud's phenomenon as idiopathic. J Rheumatol 17 (1990) 1177-1181
9. Weiner E.S., Hildebrandt S., Senecal J.L., Daniels L., Noell S., Joyal F., et al. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study. Arthritis Rheum 34 (1991) 68-77
10. Zufferey P., Depairon M., Chamot A.M., and Monti M. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 11 (1992) 536-541
11. Luggen M., Belhorn L., Evans T., Fitzgerald O., and Spencer-Green G. The evolution of Raynaud's phenomenon: a long term prospective study. J Rheumatol 22 (1995) 2226-2232
12. Landry G.J., Edwards J.M., McLafferty R.B., Taylor Jr. L.M., and Porter J.M. Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort. J Vasc Surg 23 (1996) 76-85
13. Hirschl M., and Kundi M. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology. J Rheumatol 23 (1996) 302-309
14. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158 (1998) 595-600
15. Williams H.J., Alarcon G.S., Neuner R., Steen V.D., Bulpitt K., Clegg D.O., et al. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol 25 (1998) 261-268
16. Ziegler S., Brunner M., Eigenbauer E., and Minar E. Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12 year retrospective patient analysis. Scand J Rheumatol 32 (2003) 343-347
17. Maricq H.R., Weinrich M.C., Keil J.E., and LeRoy E.C. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. J Chronic Dis 39 (1986) 423-427
18. Leppert J., Aberg H., Ringqvist I., and Sorensson S. Raynaud's phenomenon in a female population: prevalence and association with other conditions. Angiology 38 (1987) 871-877
19. Weinrich M.C., Maricq H.R., Keil J.E., McGregor A.R., and Diat F. Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 43 (1990) 1343-1349
20. Maricq H.R., Carpentier P.H., Weinrich M.C., Keil J.E., Franco A., Drouet P., et al. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol 20 (1993) 70-76
21. Inaba R., Maeda M., Fujita S., Kashiki N., Komura Y., Nagata C., et al. Prevalence of Raynaud's phenomenon and specific clinical signs related to progressive systemic sclerosis in the general population of Japan. Int J Dermatol 32 (1993) 652-655
22. Maricq H.R., Carpentier P.H., Weinrich M.C., Keil J.E., Palesch Y., Biro C., et al. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol 24 (1997) 879-889
23. Brand F.N., Larson M.G., Kannel W.B., and McGuirk J.M. The occurrence of Raynaud's phenomenon in a general population: the Framingham Study. Vasc Med 2 (1997) 296-301
24. Valter I., and Maricq H.R. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia. Scand J Rheumatol 26 (1997) 117-124
25. Palmer K.T., Griffin M.J., Syddall H., Pannett B., Cooper C., and Coggon D. Prevalence of Raynaud's phenomenon in Great Britain and its relation to hand transmitted vibration: a national postal survey. Occup Environ Med 57 (2000) 448-452
26. Suter L.G., Murabito J.M., Felson D.T., and Fraenkel L. The incidence and natural history of Raynaud's phenomenon in the community. Arthritis Rheum 52 (2005) 1259-1263
27. Maricq H.R., and Valter I. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22 Suppl 33 (2004) S5-S13
28. Silman A.J. Scleroderma-demographics and survival. J Rheumatol Suppl 48 (1997) 58-61
29. Ekenvall L., and Carlsson A. Vibration white finger: a follow up study. Br J Ind Med 44 (1987) 476-478
30. Vayssairat M., DeBure C., Cormier J.M., Bruneval P., Laurian C., and Juillet Y. Hypothenar hammer syndrome: seventeen cases with long-term follow-up. J Vasc Surg 5 (1987) 838-843